| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-TYRP1 mAbs [Flanvotumab Biosimilar] (MABL-4718) | MABL-4718 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL20 mAbs [Fletikumab Biosimilar] (MABL-4719) | MABL-4719 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL3RA/CD123;CD3E mAbs [Flotetuzumab Biosimilar] (MABL-4720) | MABL-4720 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-IFNG mAbs [Fontolizumab Biosimilar] (MABL-4721) | MABL-4721 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Foralumab Biosimilar] (MABL-4722) | MABL-4722 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Rabies Virus Antigenic Site III mAbs [Foravirumab Biosimilar] (MABL-4723) | MABL-4723 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GPRC5D;CD3E mAbs [Forimtamig Biosimilar] (MABL-4724) | MABL-4724 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-TNFRSF9/CD137/4-1BB mAbs [Exlinkibart Biosimilar] (MABL-4694) | MABL-4694 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Ezabenlimab Biosimilar] (MABL-4695) | MABL-4695 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-LIF mAbs [Falbikitug Biosimilar] (MABL-4696) | MABL-4696 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LAG3/CD223;PDCD1/CD279/PD1 mAbs [Fanastomig Biosimilar] (MABL-4697) | MABL-4697 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-VEGFA;ANGPT2 mAbs [Faricimab Biosimilar] (MABL-4698) | MABL-4698 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-FOLR1 mAbs [Farletuzumab Biosimilar] (MABL-4699) | MABL-4699 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB mAbs [Fasinumab Biosimilar] (MABL-4700) | MABL-4700 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-LAG3/CD223 mAbs [Favezelimab Biosimilar] (MABL-4701) | MABL-4701 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-KLB;FGFR1/CD331/BFGFR mAbs [Fazpilodemab Biosimilar] (MABL-4702) | MABL-4702 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-ICOS/CD278 mAbs [Feladilimab Biosimilar] (MABL-4703) | MABL-4703 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-VTCN1/B7H4 mAbs [Felmetatug Biosimilar] (MABL-4704) | MABL-4704 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADPRC1/CD38 mAbs [Felzartamab Biosimilar] (MABL-4705) | MABL-4705 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-EREG mAbs [Fepixnebart Biosimilar] (MABL-4706) | MABL-4706 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
